Evelyn Partners Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.33M Buy
1,441
+192
+15% +$195K 0.33% 57
2025
Q4
$1.34M Buy
1,249
+131
+12% +$125K 0.31% 61
2025
Q3
$853K Buy
1,118
+1,113
+22,260% +$828K 0.19% 64
2025
Q2
$3.9K Hold
5
﹤0.01% 220
2025
Q1
$4.13K Hold
5
﹤0.01% 227
2024
Q4
$3.86K Buy
+5
New +$4.14K ﹤0.01% 227

Other funds holding LLY

Evelyn Partners Asset Management's LLY Position: Q1 2026 in Review

Evelyn Partners Asset Management increased its Eli Lilly (LLY) stake by 15% in Q1 2026, buying an estimated $195K and bringing the position to 1,441 shares worth $1.33M. The position accounts for 0.33% of the portfolio, ranked #57.

Evelyn Partners Asset Management first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.34M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Evelyn Partners Asset Management held 1,441 shares of Eli Lilly worth $1.33M as of Q1 2026.
  • Evelyn Partners Asset Management bought 192 Eli Lilly shares in Q1 2026, an estimated $195K.
  • Eli Lilly made up 0.33% of Evelyn Partners Asset Management's portfolio in Q1 2026, its #57 holding.
  • Evelyn Partners Asset Management first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • Evelyn Partners Asset Management's Eli Lilly position peaked at $1.34M in Q4 2025.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Evelyn Partners Asset Management's 13F filing for Q1 2026, filed 15 May 2026.